Menu
Recruiting NCT07186699

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

Observational Lung Non-Small Cell Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Non-Interventional Study.
Who it may be relevant to
Registry conditions: Lung Non-Small Cell Carcinoma. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Qualitative Study on Detection and Treatment of Non-Small Cell Lung Cancer in Patients With a History of Alcohol or Substance Use Disorder

Overview

This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.

Detailed description

PRIMARY OBJECTIVE:

I. To identify social facilitators and barriers to detection and treatment of NSCLC by interviewing a diverse group of patients at Keck, Los Angeles General Medical Center, and Norris Cancer Center with alcohol or substance use disorder history.

OUTLINE: This is an observational study.

Patients participate in a semi-structured interview and may participate in a follow-up focus group interview in which preliminary findings are shared and feedback is elicited on study.

Interventions

  • Other Non-Interventional Study
    Non-interventional study

Primary outcome measures

  • Thematic saturation [Time frame: Up to 3 years]

Eligibility criteria

Inclusion criteria

  • \* Adults ≥ 18 years of age
  • Histopathologic or cytologic diagnosis of NSCLC
  • Received or receiving curative intent treatment (e.g. surgery, radiation therapy, systemic therapy)
  • History of alcohol use or substance use disorder (other than tobacco use disorder) within the past 10 years, predating the cancer diagnosis
  • Ability to understand and the willingness to sign a written informed consent
  • English or Spanish speaking. Due to need to conduct semi-structured interviews which can develop into free-flowing conversations we need both participant and interviewer to be fluent

Exclusion criteria

  • Patients with cognitive disability unable to maintain 30-60 minute conversation

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

United States · 2 centers
  • Los Angeles General Medical Center — Los Angeles
  • USC / Norris Comprehensive Cancer Center — Los Angeles

Identifiers

NCT: NCT07186699 · 2N-25-7 · NCI-2025-05477 · 2N-25-7 · P30CA014089

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗